Back to search
Myocardial Infarction Complicated With Cardiogenic Shock
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Myocardial Infarction Complicated With Cardiogenic Shock trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Myocardial Infarction Complicated With Cardiogenic Shock trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The observational study titled "Observational Assessment of Support with Impella Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock…
Cardiogenic shock is the most severe manifestation of acute heart failure and remains the leading cause of death in patients hospitalised with acute myocardial…
This study is a prospective, open-label, two-arm, randomized multicenter trial to identify whether immediate multi-vessel PCI would be better in clinical outcom…
This is a retrospective study from double center: Xuzhou Central Hospital and The First People's Hospital of Yancheng. Acute myocardial infarction (AMI) were sc…
Acute myocardial infarction complicated by cardiogenic shock (AMI-CS) represents the most life-threatening subtype of acute cardiovascular diseases. Current cli…